A Pilot, Randomised, Blinded, Feasibility, Safety and Biochemical and Physiological Efficacy Study of Terlipressin vs. Placebo in Cardiac Surgery Patients with the Post-operative High Cardiac Output and Hypotension syndrome
Status: Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 16 Jul 2019
Price : $35 *
At a glance
- Drugs Terlipressin (Primary)
- Indications Acute heart failure; Heart disorders; Hypotension; Postoperative complications
- Focus Therapeutic Use
- Acronyms STEP
- 18 Dec 2017 Planned initiation date changed from 1 Apr 2017 to 1 Jun 2018.
- 04 Jan 2017 Planned initiation date changed from 1 Feb 2016 to 1 Apr 2017.
- 19 Nov 2013 New trial record